Douglas Leipold
Company: Genentech
Job title: Director - Distinguished Scientific Researcher
Seminars:
Understanding & Characterizing the Impacts Of High Drug-to-Antibody Ratio (DAR) on ADC Behaviour in the Early Development Phase 11:30 am
day: Conference Day 2